206347-30-0 Usage
Uses
Used in Chemical Synthesis:
7-Bromo-2,3-dihydro-1-benzofuran is used as a chemical intermediate for the synthesis of various organic compounds. The presence of the bromine atom on the seventh carbon allows it to participate in a variety of reactions, making it a valuable building block in the creation of new molecules.
Used in Pharmaceutical Industry:
7-Bromo-2,3-dihydro-1-benzofuran is used as a starting material for the development of new pharmaceutical compounds. Its unique chemical structure and reactivity can be exploited to design and synthesize novel drug candidates with potential therapeutic applications.
Used in Material Science:
7-Bromo-2,3-dihydro-1-benzofuran is used as a component in the development of new materials with specific properties. Its chemical structure can be tailored to create materials with desired characteristics, such as improved stability, enhanced reactivity, or unique physical properties.
Used in Research and Development:
7-Bromo-2,3-dihydro-1-benzofuran is used as a research tool in academic and industrial laboratories. Its unique chemical properties make it an interesting subject for studies in organic chemistry, materials science, and related fields, contributing to the advancement of scientific knowledge and the development of new technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 206347-30-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,3,4 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 206347-30:
(8*2)+(7*0)+(6*6)+(5*3)+(4*4)+(3*7)+(2*3)+(1*0)=110
110 % 10 = 0
So 206347-30-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrO/c9-7-3-1-2-6-4-5-10-8(6)7/h1-3H,4-5H2
206347-30-0Relevant academic research and scientific papers
NOVEL BENZOFURAN DERIVATIVES, WHICH CAN BE USED IN PROPHYLAXIS OR TREATMENT OF 5-HT6 RECEPTOR-RELATED DISORDER
-
Page/Page column 168-169, (2010/02/12)
The present invention relates to compounds of formula (I): wherein P, R3, W1, and W2 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
